Movatterモバイル変換


[0]ホーム

URL:


SG11201604788UA - Testosterone gel compositions and related methods - Google Patents

Testosterone gel compositions and related methods

Info

Publication number
SG11201604788UA
SG11201604788UASG11201604788UASG11201604788UASG11201604788UASG 11201604788U ASG11201604788U ASG 11201604788UASG 11201604788U ASG11201604788U ASG 11201604788UASG 11201604788U ASG11201604788U ASG 11201604788UASG 11201604788U ASG11201604788U ASG 11201604788UA
Authority
SG
Singapore
Prior art keywords
related methods
gel compositions
testosterone gel
testosterone
compositions
Prior art date
Application number
SG11201604788UA
Inventor
Harish K Pimplaskar
Original Assignee
Upsher Smith Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upsher Smith Lab IncfiledCriticalUpsher Smith Lab Inc
Publication of SG11201604788UApublicationCriticalpatent/SG11201604788UA/en

Links

Classifications

Landscapes

SG11201604788UA2013-12-132014-12-11Testosterone gel compositions and related methodsSG11201604788UA (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US201361915742P2013-12-132013-12-13
US14/177,765US8785426B1 (en)2013-12-132014-02-11Testosterone gel compositions and related methods
PCT/US2014/069760WO2015089289A1 (en)2013-12-132014-12-11Testosterone gel compositions and related methods

Publications (1)

Publication NumberPublication Date
SG11201604788UAtrue SG11201604788UA (en)2016-07-28

Family

ID=51177812

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11201604788UASG11201604788UA (en)2013-12-132014-12-11Testosterone gel compositions and related methods

Country Status (8)

CountryLink
US (3)US8785426B1 (en)
EP (1)EP3079703A4 (en)
AU (1)AU2014362275A1 (en)
CA (1)CA2857286C (en)
HK (1)HK1223852A1 (en)
SG (1)SG11201604788UA (en)
WO (1)WO2015089289A1 (en)
ZA (1)ZA201604587B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP3332787A4 (en)*2015-09-302018-08-01Fujifilm CorporationTransdermally absorbable composition
US20200101085A1 (en)*2018-09-282020-04-02Joel StudinTranspore delivery of drugs and uses thereof
BE1030538B1 (en)*2022-05-182023-12-19Bogaert Gina Van Liposomal preparation containing encapsulated hormones, method of production and use

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5731303A (en)1985-12-041998-03-24Conrex Pharmaceutical CorporationTransdermal and trans-membrane delivery compositions
US5023252A (en)1985-12-041991-06-11Conrex Pharmaceutical CorporationTransdermal and trans-membrane delivery of drugs
US4863970A (en)1986-11-141989-09-05Theratech, Inc.Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US5332577A (en)1988-12-271994-07-26DermamedTransdermal administration to humans and animals
US5152997A (en)1990-12-111992-10-06Theratech, Inc.Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
JPH08501529A (en)1992-06-111996-02-20セラテック・インコーポレイテッド Use of glycerin to alleviate skin-penetrating drug administration
US5723114A (en)1993-03-191998-03-03Cellegy Pharmaceuticals Inc.Penetration enhancing compositions and methods of their use
US5760096A (en)1996-10-181998-06-02Thornfeldt; Carl R.Potent penetration enhancers
US5908619A (en)1997-01-091999-06-01Minnesota Mining And Manufacturing CompanyHydroalcoholic compositions thickened using surfactant/polymer complexes
US6019997A (en)1997-01-092000-02-01Minnesota Mining And ManufacturingHydroalcoholic compositions for transdermal penetration of pharmaceutical agents
ATE418988T1 (en)1997-11-102009-01-15Strakan Int Ltd PENETRATION-PROMOTING AND IRRITATION-REDUCING SYSTEMS WITH TESTOSTERONE
AU1728099A (en)1997-12-221999-07-12Alza CorporationMonoglyceride and ethyl palmitate permeation enhancer compositions
ES2359973T3 (en)1998-03-192011-05-30MERCK SHARP & DOHME CORP. LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
WO1999047073A1 (en)1998-03-191999-09-23Merck & Co., Inc.Liquid polymeric compositions for controlled release of bioactive substances
US8980290B2 (en)2000-08-032015-03-17Antares Pharma Ipl AgTransdermal compositions for anticholinergic agents
US20040198706A1 (en)2003-03-112004-10-07Carrara Dario Norberto R.Methods and formulations for transdermal or transmucosal application of active agents
ATE355854T1 (en)*2000-08-032007-03-15Antares Pharma Ipl Ag NEW COMPOSITION FOR TRANSDERMAL AND/OR TRANSMUCOSAL APPLICATION OF ACTIVE INGREDIENTS WITH A SUITABLE THERAPEUTIC MIRROR
DE60141587D1 (en)2000-08-302010-04-29Besins Int Lab PROCESS FOR TREATING EFFECTS AND INCREASING LIBIDO IN MEN
US6503894B1 (en)2000-08-302003-01-07Unimed Pharmaceuticals, Inc.Pharmaceutical composition and method for treating hypogonadism
TWI331522B (en)2001-06-222010-10-11Cpex Pharmaceuticals IncPharmaceutical composition
JP3909812B2 (en)2001-07-192007-04-25富士フイルム株式会社 Display element and exposure element
US20030175329A1 (en)2001-10-042003-09-18Cellegy Pharmaceuticals, Inc.Semisolid topical hormonal compositions and methods for treatment
FR2832311B1 (en)2001-11-212004-04-16Besins Int Belgique FILM-FORMING POWDER, COMPOSITIONS COMPRISING SAME, PREPARATION METHODS AND USES THEREOF
FR2834212B1 (en)2001-12-272004-07-09Besins Int Belgique USE OF IMMEDIATE RELEASE POWDER IN PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
MY139721A (en)2002-04-192009-10-30Cpex Pharmaceuticals IncPharmaceutical composition
EP2266533A3 (en)2002-06-252011-12-14Acrux DDS Pty LtdTransdermal delivery rate control using amorphous pharmaceutical compositions
FR2851470B1 (en)2003-02-202007-11-16Besins Int Belgique PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCTIVE DELIVERY
WO2005000241A2 (en)2003-06-232005-01-06Macrochem CorporationCompositons and methods for topical administration
EP1648364A4 (en)2003-07-112010-05-26Macrochem CorpPharmaceutical compositions for topical application
CA2624788C (en)2005-10-122011-04-19Unimed Pharmaceuticals, LlcImproved testosterone gel and method of use
US20120022033A1 (en)*2010-07-232012-01-26Biosante Pharmaceuticals, Inc.Methods for decreasing cardiovascular risk in postmenopausal women
JO3755B1 (en)2011-01-262021-01-31Ferring BvTestosterone formulations
US20130224268A1 (en)2012-02-272013-08-29Newgen Biopharma Corp.Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same

Also Published As

Publication numberPublication date
US20160310508A1 (en)2016-10-27
US9662340B2 (en)2017-05-30
WO2015089289A1 (en)2015-06-18
US20150164913A1 (en)2015-06-18
AU2014362275A1 (en)2016-07-21
US8785426B1 (en)2014-07-22
US9295675B2 (en)2016-03-29
ZA201604587B (en)2017-11-29
CA2857286A1 (en)2014-11-21
HK1223852A1 (en)2017-08-11
CA2857286C (en)2016-01-12
EP3079703A1 (en)2016-10-19
EP3079703A4 (en)2017-07-12

Similar Documents

PublicationPublication DateTitle
IL273205A (en)Compositions and methods
GB2520795B (en)Compositions and methods
IL286759A (en)Therapeutic methods and compositions
SMT201900635T1 (en)Compositions and methods for activating
EP2953474A4 (en)Compositions and methods
IL265876A (en)Compositions comprising 15-ohepa and methods of using the same
EP2951283A4 (en)Compositions and methods
GB201308072D0 (en)Compositions and methods
SG11201509136YA (en)Cenicriviroc compositions and methods of making and using the same
EP2968474A4 (en)Skin compositions and uses
GB201305813D0 (en)Compositions and methods
IL276126B (en)Compositions comprising l-4-chlorokynurenine and uses thereof
EP3065829A4 (en)Compositions and methods for treating melanoma
GB201322456D0 (en)Radiotracer compositions and methods
EP2964610A4 (en)Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
ZA201604587B (en)Testosterone gel compositions and related methods
IL246134A0 (en)Gel compositions comprising testosterone and uses thereof
GB201322617D0 (en)Methods and compositions
GB201312393D0 (en)Compositions and Methods
EP3003323A4 (en)Polysaccharide compositions and related methods
AU2013902874A0 (en)Compositions and methods
GB201319255D0 (en)Therapeutic compositions and methods
HK1227895A1 (en)Therapeutic methods and compositions
GB201300628D0 (en)Compositions comprising 15-OHEPA and methods of using the same
GB201319917D0 (en)Accelerator Compositions and Methods

[8]ページ先頭

©2009-2025 Movatter.jp